These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13606730)

  • 21. The use of hyaluronidase by iontophoresis in the treatment of generalized scleroderma.
    POPKIN RJ
    J Invest Dermatol; 1951 Feb; 16(2):97-102. PubMed ID: 14814336
    [No Abstract]   [Full Text] [Related]  

  • 22. Progressive systemic sclerosis (scleroderma).
    BEIGELMAN PM; GOLDNER F; BAYLES TB
    N Engl J Med; 1953 Jul; 249(2):45-58. PubMed ID: 13063682
    [No Abstract]   [Full Text] [Related]  

  • 23. The lung in autoimmune collagen vascular disease (A-CVD).
    Rhodes ML; Smith JD
    Heart Lung; 1977; 6(4):653-9. PubMed ID: 301521
    [No Abstract]   [Full Text] [Related]  

  • 24. [Osteonecrosis of the femoral head and inflammatory rheumatism. Statistical approach].
    Bensasson M; Lequesne M; Kahn MF; de Sèze S
    Rev Rhum Mal Osteoartic; 1972; 39(6):417-21. PubMed ID: 4538927
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative measurements on spreading phenomena in skin.
    BARER GR
    Br J Pharmacol Chemother; 1954 Sep; 9(3):346-51. PubMed ID: 13199255
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of monocyte chemoattractant protein-1 and its receptor,CCR-2, in the pathogenesis of bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    J Invest Dermatol; 2003 Sep; 121(3):510-6. PubMed ID: 12925209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 1968 interim scientific session of the American Rheumatism Association.
    Leroy EC; Kagen LJ; Kaplan D; Lightfoot RW; Sandson J; Wallace SL
    Bull Rheum Dis; 1969 Feb; 19(6):542-5. PubMed ID: 4182325
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of immunodiffusion (RID) for quantiative evaluation of immunoglobulins in the rheumatological field].
    Biddau A; Bartoletti L; Doni A
    Reumatismo; 1968; 20(5):545-9. PubMed ID: 4186692
    [No Abstract]   [Full Text] [Related]  

  • 29. [Morphohistochemical changes in the spleen in collagen diseases].
    Kaminskiĭ IuV; Kazakov IuN
    Vopr Revm; 1977; (3):24-9. PubMed ID: 20691
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical and electrophoretic study of patients with uveitis; with reference to the possible association of systemic collagen disease.
    WOODS AC; STONE HH
    Am J Ophthalmol; 1958 Jan; 45(1):11-22. PubMed ID: 13487728
    [No Abstract]   [Full Text] [Related]  

  • 31. [Research on respiratory function in 40 patients with rheumatic diseases and diffuse collagen diseases].
    CERIMELE E
    Riv Crit Clin Med; 1960 Dec; 60():417-34. PubMed ID: 13877709
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyaluronic acid-hyaluronidase system and rheumatic disease].
    RIVANO R; MANNETTI C
    Rev Rhum Mal Osteoartic; 1950 May; 17(5):211-4. PubMed ID: 15441775
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyaluronidase inhibitory substances in sera from patients with rheumatic disease.
    LAPIN L; STARKEY H
    Can Med Assoc J; 1949 May; 60(5):468-76. PubMed ID: 18117242
    [No Abstract]   [Full Text] [Related]  

  • 34. [Collagen diseases and activities of hyaluronidase].
    PELOCCHINO AM
    Gazz Med Ital; 1952 Dec; 111(12):315-24. PubMed ID: 13043807
    [No Abstract]   [Full Text] [Related]  

  • 35. The 1978 annual meeting of the American Rheumatism Association.
    Kelly WN; Barland P; Bole GG; Hahn BH; Harris ED; Lockshin M; Pearson CM; Snyderman R
    Bull Rheum Dis; 1978-1979; 29(5):988-93. PubMed ID: 33738
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanism of action of substances which inhibit the intradermal permeation of India ink in the presence of hyaluronidase].
    CAPRARO V; MELI A
    Arch Fisiol; 1952 Mar; 51(3-4):397-417. PubMed ID: 12977550
    [No Abstract]   [Full Text] [Related]  

  • 37. [Capillaroscopic pictures in diseases and syndromes of rheumatologic interest: diagnostic, prognostic, evaluative-therapeutic significance].
    Grassi W; Gasparini M; Cristofanelli P
    Clin Ter; 1984 Jan; 108(1):11-26. PubMed ID: 6232038
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.
    Koch AE; Distler O
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S3. PubMed ID: 17767741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic rheumatic disorders ("collagen disease") in childhood: lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma. II.
    Hanson V; Kornreich H
    Bull Rheum Dis; 1967 Feb; 17(6):441-6 concl. PubMed ID: 6040729
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemoglobin-hyaluronidase dispersion test during the evolution of treated or untreated rheumatic affections].
    MAHAUX J
    Acta Physiother Rheumatol Belg; 1952; 7(4):244-6. PubMed ID: 13016315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.